A 6 MONTH STUDY OF LOW-DOSE RECOMBINANT-HUMAN-ERYTHROPOIETIN ALONE AND IN COMBINATION WITH ANDROGEN FOR THE TREATMENT OF ANEMIA IN CHRONIC-HEMODIALYSIS PATIENTS
Ka. Liss et al., A 6 MONTH STUDY OF LOW-DOSE RECOMBINANT-HUMAN-ERYTHROPOIETIN ALONE AND IN COMBINATION WITH ANDROGEN FOR THE TREATMENT OF ANEMIA IN CHRONIC-HEMODIALYSIS PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1206-1206